Voice your opinion on congressional bill HR2069-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act or the SPIKE Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to determine at least annually whether certain covered drugs under Medicare were subject to a price increase that exceeded specified thresholds. Drug manufacturers must submit justifications for such price increases to the CMS, subject to civil penalties. The bill's requirements do not apply to low-cost drugs, as identified by the CMS.

House committee actions Actions

Committee
May. 21 2019	Subcommittee Hearings Held.
Apr. 04 2019	Referred to the Subcommittee on Health.
Apr. 03 2019	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Apr. 03
2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Apr. 03 2019	Introduced in House Introduced in House

House bill HR2069-116

SPIKE Act

Promote the cause!

Or use this QR code